MTB
VRTX icon

Mizuho Trust & Banking’s Vertex Pharmaceuticals VRTX Stock Holding History

Mizuho Trust & Banking’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-392,063
Closed -$34.2M – 641
2016
Q3 		$34.2M Buy
392,063
+481
+0.1% +$45.5K 0.1% 230
2016
Q2 		$33.7M Buy
391,582
+13,013
+3% +$1.12M 0.1% 226
2016
Q1 		$30.1M Buy
378,569
+12,218
+3% +$1.11M 0.1% 236
2015
Q4 		$46.3M Buy
366,351
+5,782
+2% +$698K 0.15% 145
2015
Q3 		$37.5M Buy
360,569
+10,373
+3% +$1.33M 0.13% 180
2015
Q2 		$43.2M Buy
350,196
+19,991
+6% +$2.52M 0.14% 162
2015
Q1 		$39M Buy
330,205
+21,819
+7% +$2.61M 0.13% 178
2014
Q4 		$36.6M Buy
308,386
+15,234
+5% +$1.72M 0.13% 178
2014
Q3 		$33.1M Sell
293,152
-10,149
-3% -$966K 0.12% 183
2014
Q2 		$28.7M Sell
303,301
-16,094
-5% -$1.13M 0.1% 229
2014
Q1 		$22.6M Sell
319,395
-4,140
-1% -$328K 0.08% 272
2013
Q4 		$25M Buy
323,535
+23,947
+8% +$1.67M 0.09% 239
2013
Q3 		$23.9M Hold
299,588
– – 0.1% 239
2013
Q2 		$23.9M Buy
+299,588
New +$22.1M 0.1% 237

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mizuho Trust & Banking's VRTX Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Vertex Pharmaceuticals (VRTX) in Q4 2016, closing a stake of 392,063 shares — an estimated $34.2M sold.

Mizuho Trust & Banking first reported a position in VRTX in Q2 2013 and held it in 14 quarters. The position peaked at $46.3M in Q4 2015. 483 funds tracked by Wall St. Rank hold VRTX as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Vertex Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 392,063 Vertex Pharmaceuticals shares in Q4 2016, an estimated $34.2M.
  • Mizuho Trust & Banking first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Vertex Pharmaceuticals position peaked at $46.3M in Q4 2015.
  • 483 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.